Early Wednesday morning in Asia, the US Senate passes $484 billion coronavirus (COVID-19) relief package to help small businesses, fund hospitals and availing more tests of the pandemic.
Details suggested by the CNBC mentions that the measure injects another $310 billion into a key loan program designed to keep employees on small company payrolls. The initial $350 billion in the so-called Paycheck Protection Program, created as part of the $2 trillion rescue package passed last month, dried up last week. It is unclear how many firms have actually received the money.
The new also said, “the bill passed Tuesday allocates $60 billion for small lenders as part of the small business aid program. It puts another $60 billion toward Small Business Administration disaster assistance loans and grants. It includes $75 billion in hospital relief and $25 billion for coronavirus testing.”
After the passage, US Senate Majority Leader McConnell said, “I’m proud of Congress’s new bipartisan agreement. I am just sorry that Democrats shut down emergency support for the main street in a search for partisan ‘leverage’ that never materialized.”
The bill now goes to the House for voting, expected to be out on Thursday.
After the news, the market’s risk-off sentiment seems to have paused, which in turn stopped the US dollar from its further upside. As a result, the USD/JPY drops from 107.80 to 107.70 following the news.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.